With a revenue increase of 50.81% in the fourth quarter 2024, year on year to cumulative value of $681 million, Intra Cellular Therapies Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,370,554, this marks a new company high.
Within the Healthcare sector Employees of 9 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 127, from total ranking in previous quarter at 176. Intra Cellular Therapies Inc has 202 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ITCI Revenue per Employee	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Revenue Change	50.81 %	39 %	45.67 %	52 %	50.34 %
Sales per Employee (TTM) $	3,370,554	3,038,257	2,794,683	2,544,208	2,298,861
ITCI's Total Ranking	# 127	# 176	# 174	# 153	# 146
Seq. Revenue Change	13.6 %	8.67 %	11.41 %	9.66 %	4.7 %

ITCI Company Profile >> Back to ITCI Efficiency Comparisons >> Compare ITCI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 6
Healthcare Sector	# 10
Overall Market	# 127

Revenue per Employee Statistics
High	Average	Low
$ 3,370,554	$ 1,211,704	$ 1,217
(Dec 31 2024)		(Dec 31 2017)

Financial Statements
Intra Cellular Therapies Inc 's Revenue MRQ	$ 199 Millions	Visit ITCI's Income Statement
Intra Cellular Therapies Inc 's Revenues TTM	$ 681 Millions	Visit ITCI's aggregate revenue growth
What are ITCI's Sales?		Visit ITCI's Sales by Segment

Other Ratios
Intra Cellular Therapies Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ITCI's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ITCI's Competitors
Revenue per Employee for ITCI's Suppliers
Revenue per Employee for ITCI's Customers

You may also want to know
ITCI's Sales Growth Rates	ITCI's Pe Price to earnings ratio	ITCI's Receivables Turnover Ratio	ITCI's Stock Quote
ITCI's Net Income Growth Rates	ITCI's Ps Price to Sales ratio	ITCI's Sales per Employee	ITCI's Asset Turnover Ratio
ITCI's Net Margin	ITCI's Pb Price to Book ratio	ITCI's Financial Strength Ratios	ITCI's Dividend Payout Ratio

Date modified: 2026-06-22T16:30:35+00:00

Companies with similar Revenue per Employee for 12 months ending Dec 31 2024, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Dec 31 2024	Number of Employees Dec 31 2024
American Oncology Network Inc	5,864,946.67	$ 1,759.484 Million	300
Anika Therapeutics Inc	5,625,857.14	$ 118.143 Million	21
P3 Health Partners Inc	4,688,921.88	$ 1,500.455 Million	320
Aytu Biopharma Inc	4,273,125.00	$ 68.370 Million	16
Community Health Systems Inc	4,075,483.87	$ 12,634.000 Million	3,100
Ascendis Pharma A	4,072,779.20	$ 407.278 Million	100
Pulmatrix Inc	3,903,000.00	$ 7.806 Million	2
Argenx Se	3,869,573.17	$ 4,442.270 Million	1,148
Ligand Pharmaceuticals Incorporated	3,556,021.28	$ 167.133 Million	47
Ironwood Pharmaceuticals inc	3,514,100.00	$ 351.410 Million	100
Illumina Inc	3,415,625.00	$ 4,372.000 Million	1,280
Intra cellular Therapies Inc	3,370,554.46	$ 680.852 Million	202
Protagonist Therapeutics inc	3,291,159.09	$ 434.433 Million	132
Xeris Biopharma Holdings Inc	3,124,153.85	$ 203.070 Million	65
Equillium Inc	2,935,357.14	$ 41.095 Million	14
Siga Technologies Inc	2,831,007.14	$ 138.719 Million	49
Catalyst Pharmaceuticals Inc	2,701,835.16	$ 491.734 Million	182
Innoviva Inc	2,628,125.79	$ 417.872 Million	159
Amgen Inc	2,571,076.92	$ 33,424.000 Million	13,000
Grifols Sa	2,514,120.09	$ 8,077.868 Million	3,213
Harmony Biosciences Holdings inc	2,436,583.62	$ 713.919 Million	293
Halozyme Therapeutics Inc	2,400,293.14	$ 1,015.324 Million	423
Assertio Holdings inc	2,357,754.72	$ 124.961 Million	53
Springworks Therapeutics Inc	2,280,821.43	$ 191.589 Million	84
Sarepta Therapeutics Inc	2,277,819.16	$ 1,901.979 Million	835
Indivior Pharmaceuticals Inc	2,078,000.00	$ 2,078.000 Million	1,000
United Therapeutics Corporation	2,055,285.71	$ 2,877.400 Million	1,400
Xoma Royalty Corporation	2,034,785.71	$ 28.487 Million	14
Prothena Corporation Public Limited Company	2,017,268.66	$ 135.157 Million	67
Cytomx Therapeutics Inc	2,001,492.75	$ 138.103 Million	69

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.